FMR LLC 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | ARS Pharmaceuticals, Inc. SPRY | FMR LLC | 1,202,315 1.252% | -4,167,047 (-77.61%) | Filing |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | ARS Pharmaceuticals, Inc. SPRY | FMR LLC | 5,369,362 5.726% | 1,615,625 (+43.04%) | Filing |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | ARS Pharmaceuticals, Inc. SPRY | FMR LLC | 3,753,737 10.701% | -505,875 (-11.88%) | Filing |
| 2021-02-10 09:23 am Purchase | 2021-02-09 | 13G | ARS Pharmaceuticals, Inc. SPRY | FMR LLC | 4,259,612 12.243% | 818,308 (+23.78%) | Filing |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | ARS Pharmaceuticals, Inc. SPRY | FMR LLC | 3,441,304 9.891% | 3,441,304 (New Position) | Filing |